1. Home
  2. PMT vs RAPP Comparison

PMT vs RAPP Comparison

Compare PMT & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PennyMac Mortgage Investment Trust of Beneficial Interest

PMT

PennyMac Mortgage Investment Trust of Beneficial Interest

HOLD

Current Price

$13.13

Market Cap

1.1B

Sector

Real Estate

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$30.85

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMT
RAPP
Founded
2009
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2009
2024

Fundamental Metrics

Financial Performance
Metric
PMT
RAPP
Price
$13.13
$30.85
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$14.13
$47.80
AVG Volume (30 Days)
1.1M
473.5K
Earning Date
01-29-2026
11-06-2025
Dividend Yield
12.14%
N/A
EPS Growth
N/A
N/A
EPS
0.92
N/A
Revenue
$564,655,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$29.66
N/A
P/E Ratio
$14.37
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.60
$6.43
52 Week High
$14.93
$42.27

Technical Indicators

Market Signals
Indicator
PMT
RAPP
Relative Strength Index (RSI) 63.94 59.91
Support Level $12.49 $28.03
Resistance Level $12.71 $31.52
Average True Range (ATR) 0.21 1.97
MACD 0.03 0.06
Stochastic Oscillator 79.19 85.33

Price Performance

Historical Comparison
PMT
RAPP

About PMT PennyMac Mortgage Investment Trust of Beneficial Interest

PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: